Biomerica reports real-world data showing IBS therapy effectiveness
Go back to Biomerica reports real-world data showing IBS therapy effectiveness| Biomerica, Inc. (NASDAQ: BMRA) | Delayed: 2.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.09 | 52 Week High | $3.25 | |||
| Open | $2.09 | 52 Week Low | $0.80 | |||
| Day High | $2.09 | P/E | N/A | |||
| Day Low | $2.09 | EPS | $-0.06 | |||
| Volume | 55 | |||||
| Henry Schein, Inc. (NASDAQ: HSIC) | Delayed: 80.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $80.22 | 52 Week High | $183.00 | |||
| Open | $80.22 | 52 Week Low | $142.64 | |||
| Day High | $80.22 | P/E | 16.27 | |||
| Day Low | $80.22 | EPS | $4.93 | |||
| Volume | 20 | |||||
